These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15073763)

  • 1. The effects of NHS reforms on prescribing. Report of the UK Drug Utilisation Research Group regional meeting, Liverpool Medical Institute, Mount Pleasant, Liverpool, Friday 17th May 1996.
    UK Drug Utilisation Research Group
    Pharmacoepidemiol Drug Saf; 1997 Nov; 6(6):423-8. PubMed ID: 15073763
    [No Abstract]   [Full Text] [Related]  

  • 2. Innovations in prescribing information: Report of the UK Drug Utilisation Research Group regional meeting, King's Conference Centre, University of Aberdeen, Wednesday May 31, 1995.
    Hickey F
    Pharmacoepidemiol Drug Saf; 1996 Jul; 5(4):263-7. PubMed ID: 15073829
    [No Abstract]   [Full Text] [Related]  

  • 3. Report on the Tenth Annual Scientific Meeting of the UK Drug Utilisation Research Group, Friday 11 December 1998, The Royal Society of Medicine, London.
    McGavock H
    Pharmacoepidemiol Drug Saf; 1999 May; 8(3):225-8. PubMed ID: 15073932
    [No Abstract]   [Full Text] [Related]  

  • 4. Report on the 12th Annual Scientific Meeting of the UK Drug Utilisation Research Group, Friday 15 December 2000, the Royal Society of Medicine, London.
    Girvin B
    Pharmacoepidemiol Drug Saf; 2001 May; 10(3):253-7. PubMed ID: 11501339
    [No Abstract]   [Full Text] [Related]  

  • 5. Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance.
    Godman B; Wettermark B; Hoffmann M; Andersson K; Haycox A; Gustafsson LL
    Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):65-83. PubMed ID: 19371180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of appetite suppressants in England: a putative indicator of poor prescribing practice.
    Thomas SH; Campbell M
    Pharmacoepidemiol Drug Saf; 1996 Jul; 5(4):237-46. PubMed ID: 15073826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Embedding quality improvement and patient safety at Liverpool Women's NHS Foundation Trust.
    Scholefield H
    Best Pract Res Clin Obstet Gynaecol; 2007 Aug; 21(4):593-607. PubMed ID: 17448729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of mental health nurse prescribers in Scotland.
    Snowden A
    J Psychiatr Ment Health Nurs; 2008 Aug; 15(6):471-8. PubMed ID: 18638207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial incentives linked to self-assessment of prescribing patterns: a new approach for quality improvement of drug prescribing in primary care.
    Wettermark B; Pehrsson A; Juhasz-Haverinen M; Veg A; Edlert M; Törnwall-Bergendahl G; Almkvist H; Godman B; Granath F; Bergman U
    Qual Prim Care; 2009; 17(3):179-89. PubMed ID: 19622268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of changes in antihypertensive drug utilisation following primary care educational interventions.
    Horn FE; Mandryk JA; Mackson JM; Wutzke SE; Weekes LM; Hyndman RJ
    Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):297-308. PubMed ID: 16634120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International variation in prescribing antihypertensive drugs: its extent and possible explanations.
    Fretheim A; Oxman AD
    BMC Health Serv Res; 2005 Mar; 5(1):21. PubMed ID: 15762983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highlights of the twelfth annual meeting of the National Cancer Research Institute (NCRI), 6-9 November 2016, Liverpool, UK.
    Cairns L; Nailor A; Whittaker L
    Ecancermedicalscience; 2017; 11():719. PubMed ID: 28275388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linking community pharmacy dispensing data to prescribing data of general practitioners.
    Florentinus SR; Souverein PC; Griens FA; Groenewegen PP; Leufkens HG; Heerdink ER
    BMC Med Inform Decis Mak; 2006 Apr; 6():18. PubMed ID: 16584557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Third Asia-pacific regional meeting of the international working group on harmonization of dementia drug guidelines: meeting report summary.
    Senanarong V; Chen CP; Orgogozo JM;
    Alzheimer Dis Assoc Disord; 2006; 20(4):311-2. PubMed ID: 17132979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social inequalities in health care services utilisation after eight years of health care reforms: a cross-sectional study of Estonia, 1999.
    Habicht J; Kunst AE
    Soc Sci Med; 2005 Feb; 60(4):777-87. PubMed ID: 15571895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provision of continued professional development for non-medical prescribers within a South of England Strategic Health Authority: a report on a training needs analysis.
    Green A; Westwood O; Smith P; Peniston-Bird F; Holloway D
    J Nurs Manag; 2009 Jul; 17(5):603-14. PubMed ID: 19575719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Liverpool cholera epidemic of 1832 and anatomical dissection--medical mistrust and civil unrest.
    Burrell S; Gill G
    J Hist Med Allied Sci; 2005 Oct; 60(4):478-98. PubMed ID: 16144959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Report on the 1999 Meeting of the UK Drug Utilization Research Group, Friday 18 June 1999, Keele Hall, University of Keele.
    Chapman S
    Pharmacoepidemiol Drug Saf; 2000 Jan; 9(1):65-70. PubMed ID: 19025805
    [No Abstract]   [Full Text] [Related]  

  • 20. Innovation in cardiovascular drugs: drug development portfolios. 3-4 March 1999, London, UK.
    Ahmed T
    IDrugs; 1999 May; 2(5):400-2. PubMed ID: 16155839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.